Fresenius Kabi recalls drug infusion pumps with leak risk

Fresenius Kabi USA recalled 1,546 large infusion pumps in a Class I recall, the most serious type, because of a risk of leaking products entering the electrical system and shutting down the device. 

Advertisement

The company’s Ivenix Infusion System is used in hospitals and other healthcare facilities “to give fluids to patients in precisely controlled infusion amounts and rates,” including blood, drugs and other fluids to a patient’s back or under the skin, the FDA said.

If the liquid leaks into the electrical component, the system can lose power, leading to delayed or interrupted treatments. As of April 19, there are 14 complaints, zero injuries and zero deaths related to this recall, according to the FDA.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.